[Federal Register Volume 70, Number 8 (Wednesday, January 12, 2005)]
[Notices]
[Page 2177]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-632]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Clinical Center; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the NIH Advisory Board for Clinical Research.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting. The meeting will be closed to 
the public in accordance with the provisions set forth in section 
552b(c)(6), title 5 U.S.C., as amended for discussion of personal 
qualifications and performance, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: NIH Advisory Board for Clinical Research.
    Date: January 31, 2005.
    Open: 2 p.m. to 4 p.m.
    Agenda: To review the Clinical Center operating plan, ABCR 
workgroups and Budget update.
    Place: National Institutes of Health, Building 10, 10 Center 
Drive, 4-2551, CRC Medical Board Room, Bethesda, MD 20892.
    Closed: 4 p.m. to 5 p.m.
    Agenda: For discussion of personal qualifications and 
performance the disclosure of which constitute a clearly unwarranted 
invasion of personal privacy.
    Place: National Institutes of Health, Building 10, 10 Center 
Drive, 4-2551, CRC Medical Board Room, Bethesda, MD 20892.
    Contact Person: Maureen E. Gormley, Executive Secretary, Warren 
Grant Magnuson Clinical Center, National Institutes of Health, 
Building 10, Room 6-1610, Bethesda, MD 20892, (301) 496-2897,
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

    Dated: January 6, 2005.
Laverne Y, Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-632 Filed 1-11-05; 8:45 am]
BILLING CODE 4140-01-M